Gastrointestinal Agents Market By Drug Class (Antidiarrheal, Anti-Ulcers, Laxatives, Inflammatory Bowel Disease Irritable Bowel Syndrome) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

Gastrointestinal (GI) symptoms generally include bloating, heartburn, indigestion/dyspepsia, and constipation. According to a new study, almost 74 percent of Americans suffer with digestive symptoms like gas, diarrhea, bloating and abdominal pain. In this study scope, gastrointestinal disease or disorder includes gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Among the considered conditions, incidence of GERD is the highest and commonly observed, followed by IBS and IBD. Thus rise in chronic gastrointestinal disorders and diseases, along with availability of OTC drugs are driving the growth of gastrointestinal drugs market.

The report titled “Gastrointestinal Agents Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall gastrointestinal agents market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of drugs and different geographies. The drug types studied for analyzing the overall global gastrointestinal agents market are majorly segmented into antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs

Geographically, the global gastrointestinal agents market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global gastrointestinal agents market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global gastrointestinal agents market. This report concludes with company profiles section that highlights major information about the key players engaged in global gastrointestinal agents market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Gastrointestinal Agents Market

Based on the type of drugs, the global gastrointestinal agents market is segmented as follows:

  • Antidiarrheal
    • Anti-emetics
    • Anticholinergic Agents
    • Antihistamines
    • Serotonin 5-HT3 Receptor Antagonists
    • Cannabinoid Receptor Agonists
  • Anti-ulcers
    • Histamine type 2 receptor blockers (H2 blockers)
    • Proton Pump Inhibitors
  • Laxatives
  • Inflammatory bowel disease
    • 5-Aminosalicyclic Acid (5-ASA) Derivatives
    • Immunosuppressive Agents
    • Tumor Necrosis Factor Antagonists
  • Irritable bowel syndrome
    • Antimuscarinics/Antispasmodics
    • Prokinetic Agents

Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. In base year 2016, the inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region. While, irritable bowel syndrome is anticipated to grow at the highest CAGR during the forecast period.

Gastrointestinal Agents Market

For the purpose of this study, the global gastrointestinal agents market is geographically categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Gastrointestinal Agents Market

At present, North America dominates the global gastrointestinal agents market. Particularly U.S. captures the largest market share in the regional gastrointestinal agents market. However, the region is expected to witness flat growth due to maturity of this market and no anticipated competition from potential drug. Europe is considered to be the second largest gastrointestinal agents market. Asia Pacific is anticipated to be the fastest growing market in the forecast period. Rising incidence of gastrointestinal disease and disorder, advancement in technology and overall improvement in health care infrastructure in emerging economies are the key drivers for Asia Pacific market.

Choose License Type
Published Date:  May 2017
Category:  Pharmaceuticals
Report ID:   58473
Report Format:   PDF
Pages:   120
Rating:    4.3 (50)
Connect With Us
24/7 Research Support